This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Buy Now | Get Alert | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/17/2024 | AVO | Buy Now | Mission Produce | $12.87 | 16.55% | Lake Street | Ben Klieve47% | → $15 | Initiates | → Buy | Get Alert |
05/17/2024 | IMMP | Buy Now | Immutep | $3.00 | 233.33% | Capital One | Naureen Quibria17% | → $10 | Initiates | → Overweight | Get Alert |
05/17/2024 | BODI | Buy Now | Beachbody Co | $8.46 | 53.66% | Canaccord Genuity | Susan Anderson70% | → $13 | Initiates | → Buy | Get Alert |
05/17/2024 | ABBV | Buy Now | AbbVie | $166.35 | 20.23% | Cantor Fitzgerald | Louise Chen71% | → $200 | Initiates | → Overweight | Get Alert |
05/17/2024 | REE | Buy Now | REE Automotive | $5.24 | 167.43% | Roth MKM | Craig Irwin40% | → $14 | Initiates | → Buy | Get Alert |
05/17/2024 | CFLT | Buy Now | Confluent | $32.20 | 14.91% | Oppenheimer | Ittai Kidron71% | → $37 | Initiates | → Outperform | Get Alert |
05/17/2024 | CAPR | Buy Now | Capricor Therapeutics | $6.20 | 125.81% | Oppenheimer | Leland Gershell71% | → $14 | Initiates | → Outperform | Get Alert |
05/16/2024 | TXN | Buy Now | Texas Instruments | $194.93 | -23.05% | Wells Fargo | Gary Mobley71% | → $150 | Initiates | → Underweight | Get Alert |
05/16/2024 | TCRX | Buy Now | TScan Therapeutics | $8.98 | 33.63% | BTIG | Justin Zelin61% | → $12 | Initiates | → Buy | Get Alert |
05/16/2024 | VNCE | Buy Now | Vince Holding | $1.73 | 73.41% | Small Cap Consumer Research | Eric Beder59% | → $3 | Initiates | → Buy | Get Alert |
05/16/2024 | SN | Buy Now | SharkNinja | $75.34 | 19.46% | B of A Securities | Alexander Perry21% | → $90 | Initiates | → Buy | Get Alert |
05/16/2024 | KWR | Buy Now | Quaker Houghton | $194.71 | 12.99% | Piper Sandler | Charles Neivert47% | → $220 | Initiates | → Overweight | Get Alert |
05/16/2024 | DNTH | Buy Now | Dianthus Therapeutics | $25.63 | 56.07% | HC Wainwright & Co. | Swayampakula Ramakanth68% | → $40 | Initiates | → Buy | Get Alert |
05/16/2024 | CNTX | Buy Now | Context Therapeutics | $2.01 | 123.88% | Piper Sandler | Joseph Catanzaro47% | → $4.5 | Initiates | → Overweight | Get Alert |
05/15/2024 | NAMS | Buy Now | NewAmsterdam Pharma | $20.09 | — | TD Cowen | Tyler Van Buren52% | — | Initiates | → Buy | Get Alert |
05/15/2024 | LSPD | Buy Now | Lightspeed Commerce | $15.36 | -8.85% | Jefferies | Trevor Williams59% | → $14 | Initiates | → Hold | Get Alert |
05/15/2024 | ITGR | Buy Now | Integer Holdings | $120.92 | 13.3% | Truist Securities | Richard Newitter74% | → $137 | Initiates | → Buy | Get Alert |
05/15/2024 | WVE | Buy Now | WAVE Life Sciences | $6.26 | 75.72% | Wells Fargo | Tiago Fauth40% | → $11 | Initiates | → Overweight | Get Alert |
05/15/2024 | GRNT | Buy Now | Granite Ridge Resources | $6.46 | 36.22% | Roth MKM | John White67% | → $8.8 | Initiates | → Buy | Get Alert |
Luke Jacobi is a distinguished professional known for his role as President at Benzinga, a renowned financial media outlet. With a background in business operations and management, Luke brings valuable expertise to his position, overseeing various aspects of Benzinga’s operations. His contributions play a crucial role in the company’s success, ensuring efficiency and effectiveness across different departments. Prior to his role at Benzinga, Luke has held positions that have honed his skills in leadership and strategic decision-making. With a keen understanding of the financial industry and a commitment to driving innovation, Luke continues to make significant contributions to Benzinga’s mission of providing high-quality financial news and analysis.